Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy
- PMID: 7731997
- PMCID: PMC42062
- DOI: 10.1073/pnas.92.9.3864
Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy
Abstract
In 10-30% of hypertrophic cardiomyopathy kindreds, the disease is caused by > 29 missense mutations in the cardiac beta-myosin heavy chain (MYH7) gene. The amino acid sequence similarity between chicken skeletal muscle and human beta-cardiac myosin and the three-dimensional structure of the chicken skeletal muscle myosin head have provided the opportunity to examine the structural consequences of these naturally occurring mutations in human beta-cardiac myosin. This study demonstrates that the mutations are related to distinct structural and functional domains. Twenty-four are clustered around four specific locations in the myosin head that are (i) associated with the actin binding interface, (ii) around the nucleotide binding site, (iii) adjacent to the region that connects the two reactive cysteine residues, and (iv) in close proximity to the interface of the heavy chain with the essential light chain. The remaining five mutations are in the myosin rod. The locations of these mutations provide insight into the way they impair the functioning of this molecular motor and also into the mechanism of energy transduction.
Similar articles
-
Functional consequences of mutations in the smooth muscle myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy.J Biol Chem. 2000 Sep 8;275(36):28045-52. doi: 10.1074/jbc.M005485200. J Biol Chem. 2000. PMID: 10882745
-
Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy.Biophys J. 1998 Dec;75(6):3023-30. doi: 10.1016/S0006-3495(98)77743-4. Biophys J. 1998. PMID: 9826622 Free PMC article.
-
The cardiac myosin heavy chain Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the actin- or ATP-binding capacities of two size-limited recombinant myosin heavy chain fragments.Biochem J. 1995 Mar 1;306 ( Pt 2)(Pt 2):345-51. doi: 10.1042/bj3060345. Biochem J. 1995. PMID: 7887887 Free PMC article.
-
Molecular basis of hypertrophic and dilated cardiomyopathy.Tex Heart Inst J. 1994;21(1):6-15. Tex Heart Inst J. 1994. PMID: 8180512 Free PMC article. Review.
-
Myosin mutations in hypertrophic cardiomyopathy and functional implications.Herz. 1994 Apr;19(2):75-83. Herz. 1994. PMID: 8194835 Review.
Cited by
-
Myofibre Hyper-Contractility in Horses Expressing the Myosin Heavy Chain Myopathy Mutation, MYH1E321G.Cells. 2021 Dec 6;10(12):3428. doi: 10.3390/cells10123428. Cells. 2021. PMID: 34943936 Free PMC article.
-
Characterization of mutant myosins of Dictyostelium discoideum equivalent to human familial hypertrophic cardiomyopathy mutants. Molecular force level of mutant myosins may have a prognostic implication.J Clin Invest. 1997 Mar 1;99(5):1010-5. doi: 10.1172/JCI119228. J Clin Invest. 1997. PMID: 9062359 Free PMC article.
-
Mutations of the beta myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis.Heart. 2003 Oct;89(10):1179-85. doi: 10.1136/heart.89.10.1179. Heart. 2003. PMID: 12975413 Free PMC article. Clinical Trial.
-
A myosin family reunion.J Muscle Res Cell Motil. 1996 Feb;17(1):7-22. doi: 10.1007/BF00140320. J Muscle Res Cell Motil. 1996. PMID: 8740428 Review. No abstract available.
-
Molecular genetic dissection of mouse unconventional myosin-VA: head region mutations.Genetics. 1998 Apr;148(4):1951-61. doi: 10.1093/genetics/148.4.1951. Genetics. 1998. PMID: 9560408 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases